Novel Coronavirus (COVID-2019) update: Please refer to the Centers for Disease Control and Prevention (CDC) website,

About Cancer Research & Drug Development

Cancer R&D 2020 VIRTUAL

Over the past few weeks, the United Scientific Group and Cancer R&D-2020 committee members have been monitoring worldwide developments of coronavirus (COVID-19) outbreak. After careful consideration of the evolving concerns around COVID-19, and in alignment with the best practices laid out by the CDC, WHO, and other relevant entities. Subsequently and with a view of prioritizing the health and safety of our attendees, we have had to make what we feel is the positive step of taking Cancer R&D 2020 fully virtual on October 26-28, 2020.

The original program at the conference will be the same as much as possible. Our sincere thanks to our speakers, participants, sponsors, and exhibitors for your understanding, support, and flexibility.

To learn more, please read our Covid-19 FAQ. If you have any questions or need additional information, please contact us at

Cancer R&D 2020 Symposium

  • Transport and Metabolism in Drug Development
    Chair: Yan Zhang, Director DMPK, Nuvation Bio,NY
    Co-Chair : Jason Boer, Director, Incyte Corporation, DE
  • New Concepts and Potential Chemotherapy for Treatment & Prevention of Cancers
    Chairs: Leslie C. Costello, University of Maryland Greenebaum Comprehensive Cancer Center, MD

About Cancer Research & Drug Development Conference 2020

International Conference on Cancer Research and Drug Development concluded in Baltimore in Oct 21-23,2019. As promised, we gathered 135 attendees at this Cancer Conference. We are happy to share that all the cancer conference attendees, speakers and students were very much impressed with the quality of science presented at this cancer meeting. Cancer conferences by United Scientific group are launched in 2016 at Baltimore. USG’s Cancer Conference was at first launched in 2016, with an excellent organizing committee from various institutes. Cancer R&D conference 2019 had 150 attendees and we are glad to share that 26 speakers are from NCI/NIH and many more from University of Maryland and JHU. Having 150 speakers every year at our cancer conference from 17 different countries we are launching our next edition in Baltimore, MD. United Scientific Group (A Non-Profit Organization) hosted four Cancer Conferences with a title "Cancer Research and Targeted Therapy” thrice in USA and once in UK. Having a total of 200 participants and their positive notes we are happy to announce our next Cancer Conference “Fifth International Conference on Cancer Research and Drug Development 2020". Honored with a set of eminent speakers Dr. Andrew Schally Nobel Laureate 1977, Dr. Polly Matzinger, Dr. Thomas Waldmann, Dr. Danny Welch, Dr. Leslie Costello, Dr. Suresh Ambudkar, Dr. Ying Xu, Dr. Michael Gottesman and Dr. Carolyn Compton and many more speakers worldwide. We are happy to welcome you to join the three-day cancer conference with your recent developments in the cancer research. Here we are to promise again to gather interesting talks from all over the world at Cancer R&D-2020 conference.